Clinical Trial Detail

NCT ID NCT02829099
Title A Study of Safety, Pharmacokinetics and Pharmacodynamics of JNJ-64457107 in Participants With Advanced Stage Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Janssen Research & Development, LLC
Indications

lung non-small cell carcinoma

pancreatic cancer

skin melanoma

Advanced Solid Tumor

Therapies

JNJ-64457107

Age Groups: senior adult

No variant requirements are available.